NCT04654351View on ClinicalTrials.gov

A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

PHASE3CompletedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

July 27, 2021

Study Completion Date

July 27, 2021

Conditions

Hereditary Angioedema

Interventions

DRUG

TAK-667

TAK-667 single SC administration

Trial Locations (3)

Unknown

Aich Medical University Hospital, Nagakute

Juntendo University Hospital, Bunkyo-ku

Kagoshima University Hospital, Kagoshima

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY